Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Ariana Berenson"'
Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients
Autor:
Michael Ghermezi, Mingjie Li, Suzie Vardanyan, Nika Manik Harutyunyan, Jillian Gottlieb, Ariana Berenson, Tanya M. Spektor, Claudia Andreu-Vieyra, Sophia Petraki, Eric Sanchez, Kyle Udd, Cathy S. Wang, Regina A. Swift, Haiming Chen, James R. Berenson
Publikováno v:
Haematologica, Vol 102, Iss 4 (2017)
B-cell maturation antigen is expressed on plasma cells. In this study, we have identified serum B-cell maturation antigen as a novel biomarker that can monitor and predict outcomes for multiple myeloma patients. Compared to healthy donors, patients w
Externí odkaz:
https://doaj.org/article/0b663bd3368b4fe5b3a477549ec2782f
Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients
Autor:
Michael Ghermezi, Suzie Vardanyan, Claudia Andreu-Vieyra, Sophia Petraki, Kyle Udd, Cathy S Wang, Regina A. Swift, Tanya M. Spektor, Nika M Harutyunyan, Mingjie Li, Eric Sanchez, Jillian Gottlieb, James R. Berenson, Ariana Berenson, Haiming Chen
Publikováno v:
Haematologica
B-cell maturation antigen is expressed on plasma cells. In this study, we have identified serum B-cell maturation antigen as a novel biomarker that can monitor and predict outcomes for multiple myeloma patients. Compared to healthy donors, patients w
Autor:
Youram Nassir, Suzie Vardanyan, Benjamin Eades, Tanya M. Spektor, James Wang, Ariana Berenson, Michael David, Shahrooz Eshaghian, Regina A. Swift, Jillian Gottlieb, James R. Berenson, Nika M Harutyunyan, Kyle Udd, Ran Halleluyan
Publikováno v:
Annals of Hematology. 96:449-459
New classes of drugs including the proteasome inhibitors (PI) bortezomib and, more recently, carfilzomib and the immunomodulatory agent lenalidomide have shown improved outcomes for multiple myeloma (MM) patients during the past decade. However, most
Autor:
Tanya M. Spektor, Michael David, James Wang, Kyle Udd, Ariana Berenson, Nika M Harutyunyan, Ran Halleluyan, Jillian Gottlieb, Youram Nassir, Suzie Vardanyan, Regina A. Swift, Shahrooz Eshaghian, Benjamin Eades, James R. Berenson
Publikováno v:
Annals of Hematology. 96:441-448
Despite recent advances made in its treatment, multiple myeloma (MM) remains an incurable B cell malignancy. Thus, the objective for treating these patients is to prolong overall survival (OS) and preserve patients’ quality of life. We have analyze
Autor:
Eric Sanchez, James R. Berenson, Jennifer Li, Haiming Chen, Cathy S. Wang, Jing Shen, James Wang, Eric Wirtschafter, Ariana Berenson, Zhi-Wei Li, Benjamin Bonavida, Mingjie Li
Publikováno v:
International journal of oncology. 37(1)
Enhanced angiogenesis is a hallmark of solid tumors and hematological malignancies. Anti-angiogenic therapeutic approaches have recently been shown to be effective for the treatment of certain cancers. Endothelial cells migrating to tumors provide th
Autor:
Thomas F. Deuel, Haiming Chen, Jonathan W. Said, Jennifer Li, Eric Sanchez, Mingjie Li, James R. Berenson, Cathy S. Wang, Pablo Perez-Pinera, Jeffrey A. Steinberg, Yunchao Chang, Benjamin Bonavida, Ariana Berenson, Zhaohui Zeng, Richard A. Campbell, Dror Shalitin, Michael Share, Dorina Gui, Ronald J. Berenson
Enhanced angiogenesis is a hallmark of cancer. Pleiotrophin (PTN) is an angiogenic factor that is produced by many different human cancers and stimulates tumor blood vessel formation when it is expressed in malignant cancer cells. Recent studies show
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::298314410a4d8a6dfe7f6d263e90c021
https://europepmc.org/articles/PMC2651013/
https://europepmc.org/articles/PMC2651013/
Autor:
Suzie Vardanyan, Claudia Andreu-Vieyra, Judith Finlay, Joseph Ben-Zvi, Nika M Harutyunyan, Mingjie Li, Ariana Berenson, George Tang, Eric Sanchez, Michael Ghermezi, Gigi Garzio, James R. Berenson, Jillian Gottlieb, Cathy Wang, Haiming Chen
Publikováno v:
Blood. 124:2125-2125
Introduction: The levels of serum monoclonal immunoglobulins (M-Igs) are used to monitor multiple myeloma (MM) patients. However, these assessments do not discriminate between normal polyclonal immunoglobulins (uninvolved) and M-Igs since they cannot
Autor:
Claudia Andreu-Vieyra, Eric Sanchez, James R. Berenson, Nika M Harutyunyan, Michael Ghermezi, Jillian Gottlieb, Suzie Vardanyan, Regina A. Swift, Ariana Berenson
Publikováno v:
Blood. 124:3405-3405
Introduction:B-cell maturation antigen (BCMA) is a tumor necrosis factor receptor family member that is expressed on normal and malignant B-cells, including those from patients (pts) with multiple myeloma (MM). Our group has recently shown that this
Autor:
Regina A. Swift, Claudia Andreu-Vieyra, Jillian Gottlieb, James R. Berenson, Michael Ghermezi, Ariana Berenson, Ran Halleluyan, Suzie Vardanyan, Nika M Harutyunyan
Publikováno v:
Blood. 124:5771-5771
Introduction: Despite the advances for treating multiple myeloma (MM) patients (pts), it remains an incurable B-cell malignancy. Thus, the objective for treating these pts is to prolong overall survival (OS) and preserve quality of life. New classes
Publikováno v:
Blood. 124:5769-5769
Introduction: In addition to breast and colorectal cancers, multiple myeloma has also been associated with vitamin D deficiency. Given the role of vitamin D in calcium absorption and bone metabolism, it is crucial to maintain sufficient levels for mu